TATA Uganda Limited v Uganda Revenue Authority [2021] UGTAT 31
Observed later treatment
No later-treatment classification is recorded for this judgment.
Citator coverage is limited to judgments in the Wakilii corpus and source-matched treatment records. Absence of a signal is not an assertion that the case remains good law.
AI-generated summary. This summary was generated by AI from the full text of the judgment. It may contain errors or omissions—always read the source judgment before relying on it.
Holding
The Tribunal held that Zecaf herbal cough lozenges were correctly classifiable as medicaments under HSC 3004.90 attracting 0% import duty, not as sugar confectionary under HSC 1704.90. The measured doses, ingredients with therapeutic properties, and packaging for retail sale demonstrated therapeutic and prophylactic uses. The assessment of Shs. 726,666,331 was set aside. The Tribunal applied the principle of legitimate expectation, finding that URA's consistent classification over several years estopped it from reclassification.
Outcome
Assessment set aside; deposit refunded to applicant
Facts
TATA Uganda Limited imported Zecaf herbal cough lozenges since 2014, classifying them under HSC 3004.90 as medicaments attracting 0% import duty. In 2018, Uganda Revenue Authority audited the applicant and reclassified the imports under HSC 1704.90 as sugar confectionary, giving rise to a tax liability of Shs. 726,666,331. The lozenges contained active ingredients including Glycyrrhiza glabra (liquorice), Zingiber officinalis (ginger), Emblica officinalis, and menthol, and were approved as drugs by the National Drug Authority. The applicant objected, paid 30% of the disputed tax (Shs. 217,999,899), and filed this application. URA relied on a World Customs Organization email suggesting classification under heading 17.04 and cited Practice Note 2007 excluding lozenges from medicament classification for VAT purposes.
Issues
- Whether the applicant is liable to pay customs duty on Zecaf herbal cough lozenges?
- What remedies are available?
Orders
- The assessment of Shs. 726,666,331 is set aside.
- The 30% of the tax in dispute deposited is refunded.
- The respondent pays the costs of this application.
Rules and key headnotes
Legislation cited (10)
- Tax Appeals Tribunal Act s.18
- National Drug Policy and Authority Act s.5
- Constitution of Uganda Article 152
- Uganda Revenue Authority Act s.3
- East African Community Customs External Tariff
- International Convention on the Harmonized Commodity Description and Coding System Article 3(a)
- International Convention on the Harmonized Commodity Description and Coding System Article 7
- International Convention on the Harmonized Commodity Description and Coding System Article 8
- World Trade Facilitation Agreement Article 3(9)
- International Convention on the Simplification and Harmonization of Customs Procedures Article 9.9
Cases cited (13)
- Norbook Uganda Limited v Uganda Revenue Authority (TAT Application No. 18 of 2018)
- Republic v Kenya Revenue Authority ex parte Universal Corporation Limited MA 460 of 2013
- Solar Now Services Limited v Uganda Revenue Authority (TAT Application No. 13 of 2017)
- M-KOPA Uganda Ltd. v Uganda Revenue Authority (TAT Application No. 15 of 2017)
- Vtech Electronics (UK) PLC High Court, Chancery Division
- Bioforce GmbH v Oberfinzdirektion Muchen [1997] EUECJ C-405/95
- Richard Babumba v James Ssali Babumba Civil Suit 78 of 2012
- Bioforce GmbH v Oberfinanzdirecktion Muchen 1993 ECR 1-45
- Elementis Specialties Inc v The Commissioners of Customs and Excise COO117
- Council of Civil Service Union v Minister for Civil Service [1985] AC 374
- Republic v Kenya Revenue Authority Exparte Shake Distributors Limited {2012}
- Justice Kalpana Rawal v Judicial Service Commission and 3 others {2016] EKLR
- R v Inland Revenue Commissioner ex parte MFK Underwriting Agents Limited [1989] STC 873
Full judgment
The original judgment as reported. Read the original PDF before relying on any passage.